ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Gilead Aims To Take A Giant Lead In The CAR-T Space – Seeking Alpha

Seeking AlphaGilead Aims To Take A Giant Lead In The CAR-T SpaceSeeking AlphaGilead Sciences creates a collaboration agreement with Pfizer to enhance CAR-T therapy with another immunotherapy drug built to spur T-cell immune response. The future of trea… Continue reading

2018-01-22 Michael Zand NEWS

FDA OKs gene therapy to treat rare form of vision impairment – The Daily Iowan

The Daily IowanFDA OKs gene therapy to treat rare form of vision impairmentThe Daily IowanThe days of a rare inherited eye disease that can cause blindness may be limited because of a newly approved gene therapy. The Stephen A. Wynn Institute for Visio… Continue reading

2018-01-22 Michael Zand NEWS

Scientists Warn World Is Now “More Vulnerable to Smallpox” After Controversial Virus Synthesis – ScienceAlert

Scientists Warn World Is Now "More Vulnerable to Smallpox" After Controversial Virus SynthesisScienceAlertWhile the purpose of the exercise was ostensibly to investigate how the synthetic horsepox virus could help us research safer new forms … Continue reading

2018-01-22 Michael Zand NEWS

Cynata Therapeutics advance to second cohort in stem cell trial – Small Caps

Continue reading

2018-01-22 Michael Zand NEWS

Some Melanoma Respond to Immunotherapy Beyond Progression – Cancer Network

Some Melanoma Respond to Immunotherapy Beyond ProgressionCancer NetworkTo assess the clinical benefit in patients who continue immunotherapy beyond traditionally defined progression, the investigators conducted a pooled analysis of eight multicenter cl… Continue reading

2018-01-22 Michael Zand NEWS

Stem Cells for Urinary Incontinence: Functional Differentiation or Cytokine Effects? – UroToday


Small Caps

Cynata Therapeutics advance to second cohort in stem cell trial
Small Caps
Stem cell and regenerative medicine company Cynata Therapeutics (ASX: CYP) has received an encouraging early response from the clinical trials of its stem cell product CYP-001, which began in November to treat steroid-resistant graft-versus-host …
Encouraging Early Safety and Efficacy Data in Cynata’s Phase 1 Trial of CYP-001 in GvHD; DSMB Recommendation to …Nasdaq
HC Wainright repeats ‘buy’ on Cynata as ongoing trial is cleared by data safety monitoring boardProactive Investors UK

all 4 news articles »

Continue reading

2018-01-22 Michael Zand NEWS

How Stem Cells Can Reverse Opioid Tolerance – Pain News Network

Pain News NetworkHow Stem Cells Can Reverse Opioid TolerancePain News NetworkIn that quest, some have found an answer in stem cells. In a recent study, Dr. Jianguo Cheng and scientists at the Cleveland Clinic and the Affiliated Hospital of Qingdao Univ… Continue reading

2018-01-21 Michael Zand NEWS

Living Architecture ‘Astrocyte’ Questions Whether Buildings Can Think and Care – ArchDaily

Stem Cells for Urinary Incontinence: Functional Differentiation or Cytokine Effects?
UroToday
Clinical trials of periurethral stem cell injection have been underway and basic science research has demonstrated the efficacy of both local and systemic stem cell therapies. Results differ as to whether stem cells have a therapeutic effect by …
Erectile Dysfunction And Stem Cell TherapyCheckbiotech.org (press release)
Perinatal Stem Cells. 2nd Edition – Healthcare, Healthcare Services, Therapeutic Area, Women’s Health IndustriesMilTech
Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury …satPRnews (press release)

all 9 news articles »

Continue reading

2018-01-21 Michael Zand NEWS
  • 1
  • …
  • 638
  • 639
  • 640
  • 641
  • 642
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

ArchDaily

Living Architecture ‘Astrocyte’ Questions Whether Buildings Can Think and Care
ArchDaily
The synthetic biology system has the potential to self-repair and alters space through the kinetic mechanisms that integrate structure and motion – two opposing characteristics. Together they connect with humans much like how nature does in the …

and more »